Dr. Faries is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11800 Wilshire Blvd
Fl 3
Los Angeles, CA 90025Phone+1 310-967-1884Fax+1 310-967-1744
Education & Training
- University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2002
- Weill Cornell MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2002 - 2026
- CT State Medical License 2010 - 2015
- PA State Medical License 1996 - 2004
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Start of enrollment: 2004 Sep 30
- Minimally Invasive Groin Dissection for Melanoma Start of enrollment: 2012 Jun 01
- Trial of pIL-12 Electroporation Malignant Melanoma Start of enrollment: 2012 Feb 14
Publications & Presentations
PubMed
- 32 citationsMelanoma brain metastases: is it time to reassess the bias?Jaclyn C. Flanigan, Mark Faries, Mario Sznol, Stephan Ariyan, James B. Yu
Current Problems in Cancer. 2011-07-01 - 98 citationsRecent Advances in the Treatment of Melanoma.Brendan D. Curti, Mark B. Faries
The New England Journal of Medicine. 2021-06-09 - 65 citationsLate recurrence in melanoma: clinical implications of lost dormancy.Mark B. Faries, Shawn T. Steen, Xing Ye, Myung Sim, Donald L. Morton
Journal of the American College of Surgeons. 2013-07-01
Journal Articles
- Microsatellitosis in Patients with MelanomaRichard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology
Press Mentions
- GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers SymposiumDecember 13th, 2019
- Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated DiseaseJuly 17th, 2019
- Lymph-Node Dissection Increases Rates of Regional Disease ControlSeptember 1st, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: